Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification
The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
NON-INVASIVE MAGNETIC STIMULATION OF HUMAN MOTOR CORTEX
Barker, A. T., Jalinous, R., & Freeston, I. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92413-4 · Cited by 4,460
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Ehringer, H., & Hornykiewicz, O. (1960) · Klinische Wochenschrift · doi:10.1007/bf01485901 · Cited by 1,867
Levodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
Haber, S. N., Fudge, J. L., & McFarland, N. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02369.2000 · Cited by 1,610
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Kordower, J. H., Olanow, C. W., Dodiya, H. B., Chu, Y., Beach, T. G., Adler, C. H., Halliday, G. M., & Bartus, R. T. (2013) · Brain · doi:10.1093/brain/awt192 · Cited by 1,286
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease
Redgrave, P., Rodriguez, M., Smith, Y., Rodriguez-Oroz, M. C., Lehericy, S., Bergman, H., Agid, Y., DeLong, M. R., & Obeso, J. A. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2915 · Cited by 1,134
Jahanshahi, M., Jenkins, I. H., Brown, R. G., Marsden, C. D., Passingham, R. E., & Brooks, D. J. (1995) · Brain · doi:10.1093/brain/118.4.913 · Cited by 999
Matsuda, W., Furuta, T., Nakamura, K. C., Hioki, H., Fujiyama, F., Arai, R., & Kaneko, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4029-08.2009 · Cited by 865
Pathophysiology of the basal ganglia in Parkinson's disease
Obeso, J. A., Rodriguez-Oroz, M. C., Rodriguez, M., Lanciego, J. L., Artieda, J., Gonzalo, N., & Olanow, C. W. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00028-8 · Cited by 844
Self-citationSlower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10609 · Cited by 829
The cerebellum in Parkinson’s disease
Wu, T., & Hallett, M. (2013) · Brain · doi:10.1093/brain/aws360 · Cited by 748
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745
Dopamine Receptor Binding Enhancement Accompanies Lesion-Induced Behavioral Supersensitivity
Creese, I., Burt, D. R., & Snyder, S. H. (1977) · Science · doi:10.1126/science.877576 · Cited by 712
Playford, E. D., Jenkins, I. H., Passingham, R. E., Nutt, J., Frackowiak, R. S. J., & Brooks, D. J. (1992) · Annals of Neurology · doi:10.1002/ana.410320206 · Cited by 611
Compensations after lesions of central dopaminergic neurons: some clinical and basic implications
Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace, A. A., & Stricker, E. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90112-n · Cited by 609
Ridding, M. C., Sheean, G., Rothwell, J. C., Inzelberg, R., & Kujirai, T. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.5.493 · Cited by 598
Lee, C. S., Samii, A., Sossi, V., Ruth, T. J., Schulzer, M., Holden, J. E., Wudel, J., Pal, P. K., De La Fuente-Fernandez, R., Calne, D. B., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<493::aid-ana13>3.0.co;2-4 · Cited by 580
Biochemical aspects of Parkinson's disease
Hornykiewicz, O. (1998) · Neurology · doi:10.1212/wnl.51.2_suppl_2.s2 · Cited by 564
Changes in excitability of motor cortical circuitry in patients with parkinson's disease
Ridding, M. C., Rothwell, J. C., & Inzelberg, R. (1995) · Annals of Neurology · doi:10.1002/ana.410370208 · Cited by 563
Functional diversity and specificity of neostriatal interneurons
Tepper, J. M., & Bolam, J. P. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.10.003 · Cited by 526
Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa
Haslinger, B., Erhard, P., Kämpfe, N., Boecker, H., Rummeny, E., Schwaiger, M., Conrad, B., & Ceballos-Baumann, A. O. (2001) · Brain · doi:10.1093/brain/124.3.558 · Cited by 486
Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A. R., Bioulac, B., Brotchie, J. M., & Gross, C. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06853.2001 · Cited by 483
The metabolic topography of parkinsonism
Eidelberg, D., Moeller, J. R., Dhawan, V., Spetsieris, P., Takikawa, S., Ishikawa, T., Chaly, T., Robeson, W., Margouleff, D., Przedborski, S., et al. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.99 · Cited by 455
Living on the edge with too many mouths to feed: Why dopamine neurons die
Bolam, J. P., & Pissadaki, E. K. (2012) · Movement Disorders · doi:10.1002/mds.25135 · Cited by 436
Jenkins, I. H., Fernandez, W., Playford, E. D., Lees, A. J., Frackowiak, R. S. J., Passingham, R. E., & Brooks, D. J. (1992) · Annals of Neurology · doi:10.1002/ana.410320608 · Cited by 419
The functional role of beta oscillations in Parkinson's disease
Little, S., & Brown, P. (2014) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70013-0 · Cited by 415
Mallet, N., Ballion, B., Le Moine, C., & Gonon, F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4439-05.2006 · Cited by 413
de la Fuente-Fernandez, R. (2004) · Brain · doi:10.1093/brain/awh290 · Cited by 402
Taverna, S., Ilijic, E., & Surmeier, D. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5493-07.2008 · Cited by 399
Subthalamic nucleus‐mediated excitotoxicity in parkinson's disease: A target for neuroprotection
Rodriguez, M. C., Obeso, J. A., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440726 · Cited by 396
Self-citationBrooks, D. J., Ibanez, V., Sawle, G. V., Playford, E. D., Quinn, N., Mathias, C. J., Lees, A. J., Marsden, C. D., Bannister, R., & Frackowiak, R. S. J. (1992) · Annals of Neurology · doi:10.1002/ana.410310209 · Cited by 396
Changes in network activity with the progression of Parkinson's disease
Huang, C., Tang, C., Feigin, A., Lesser, M., Ma, Y., Pourfar, M., Dhawan, V., & Eidelberg, D. (2007) · Brain · doi:10.1093/brain/awm086 · Cited by 395
Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
Aubert, I., Guigoni, C., Håkansson, K., Li, Q., Dovero, S., Barthe, N., Bioulac, B. H., Gross, C. E., Fisone, G., Bloch, B., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20296 · Cited by 387
Dopaminergic control of synaptic plasticity in the dorsal striatum
Centonze, D., Picconi, B., Gubellini, P., Bernardi, G., & Calabresi, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01485.x · Cited by 364
The basal ganglia in Parkinson's disease: Current concepts and unexplained observations
Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., & Olanow, C. W. (2009) · Annals of Neurology · doi:10.1002/ana.21481 · Cited by 359
Self-citationNetwork modulation in the treatment of Parkinson's disease
Asanuma, K. (2006) · Brain · doi:10.1093/brain/awl162 · Cited by 358
A Complex Program of Striatal Gene Expression Induced by Dopaminergic Stimulation
Berke, J. D., Paletzki, R. F., Aronson, G. J., Hyman, S. E., & Gerfen, C. R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05301.1998 · Cited by 356
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
Bezard, E., Gross, C. E., & Brotchie, J. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00038-9 · Cited by 350
Volume transmission in the CNS and its relevance for neuropsychopharmacology
Zoli, M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01343-7 · Cited by 344
Molecular effects of dopamine on striatal-projection pathways
Gerfen, C. R. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00019-7 · Cited by 341
The Primate Thalamus Is a Key Target for Brain Dopamine
Sánchez-González, M. Á., García-Cabezas, M. Á., Rico, B., & Cavada, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0968-05.2005 · Cited by 319
When Does Parkinson Disease Start?
Savica, R., Rocca, W. A., & Ahlskog, J. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.135 · Cited by 312
Serotonin in Parkinson's disease
Politis, M., & Niccolini, F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.037 · Cited by 306
Tanaka, H., Kannari, K., Maeda, T., Tomiyama, M., Suda, T., & Matsunaga, M. (1999) · NeuroReport · doi:10.1097/00001756-199902250-00034 · Cited by 302
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease
Zaja-Milatovic, S., Milatovic, D., Schantz, A. M., Zhang, J., Montine, K. S., Samii, A., Deutch, A. Y., & Montine, T. J. (2005) · Neurology · doi:10.1212/01.wnl.0000150591.33787.a4 · Cited by 300
STRIATONIGRAL DEGENERATION: A CLINICOPATHOLOGICAL STUDY
FEARNLEY, J. M., & LEES, A. J. (1990) · Brain · doi:10.1093/brain/113.6.1823 · Cited by 296
Fieblinger, T., Graves, S. M., Sebel, L. E., Alcacer, C., Plotkin, J. L., Gertler, T. S., Chan, C. S., Heiman, M., Greengard, P., Cenci, M. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6316 · Cited by 295
Synaptic Dysfunction in Parkinson’s Disease
Picconi, B., Piccoli, G., & Calabresi, P. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_24 · Cited by 290
Synchronized neural oscillations and the pathophysiology of Parkinsonʼs disease
Oswal, A., Brown, P., & Litvak, V. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000034 · Cited by 267
Subthalamotomy in parkinsonian monkeys Behavioural and biochemical analysis
Guridi, J., Herrero, M. T., Luquin, M. R., Guillén, J., Ruberg, M., Laguna, J., Vila, M., Javoy-Agid, F., Agid, Y., Hirsch, E., et al. (1996) · Brain · doi:10.1093/brain/119.5.1717 · Cited by 263
Self-citationAdams, J. R., van Netten, H., Schulzer, M., Mak, E., Mckenzie, J., Strongosky, A., Sossi, V., Ruth, T. J., Lee, C. S., Farrer, M., et al. (2005) · Brain · doi:10.1093/brain/awh607 · Cited by 262
Raz, A., Feingold, A., Zelanskaya, V., Vaadia, E., & Bergman, H. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.3.2083 · Cited by 261
A new dynamic model of the cortico-basal ganglia loop
(2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)43043-4 · Cited by 259
Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., Lee, C. S., McKenzie, J., McCormick, S., Samii, A., Troiano, A., et al. (2009) · Brain · doi:10.1093/brain/awp209 · Cited by 259
De La Fuente‐Fernández, R., Lu, J., Sossi, V., Jivan, S., Schulzer, M., Holden, J. E., Lee, C. S., Ruth, T. J., Calne, D. B., & Stoessl, A. J. (2001) · Annals of Neurology · doi:10.1002/ana.65 · Cited by 247
Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease
McNeill, T. H., Brown, S. A., Rafols, J. A., & Shoulson, I. (1988) · Brain Research · doi:10.1016/0006-8993(88)90124-2 · Cited by 246
Henderson, J. M. (2000) · Brain · doi:10.1093/brain/123.7.1410 · Cited by 244
Differential Excitability and Modulation of Striatal Medium Spiny Neuron Dendrites
Day, M., Wokosin, D., Plotkin, J. L., Tian, X., & Surmeier, D. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1840-08.2008 · Cited by 243
Cortical inhibition in Parkinson's disease: A study with paired magnetic stimulation
Berardelli, A., Rona, S., Inghilleri, M., & Manfredi, M. (1996) · Brain · doi:10.1093/brain/119.1.71 · Cited by 241
Wallace, B. A., Ashkan, K., Heise, C. E., Foote, K. D., Torres, N., Mitrofanis, J., & Benabid, A.-L. (2007) · Brain · doi:10.1093/brain/awm137 · Cited by 235
Piallat, B., Benazzouz, A., & Benabid, A. L. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01603.x · Cited by 234
Cenci, M. A. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00242 · Cited by 233
Dickinson, S. D., Sabeti, J., Larson, G. A., Giardina, K., Rubinstein, M., Kelly, M. A., Grandy, D. K., Low, M. J., Gerhardt, G. A., & Zahniser, N. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720148.x · Cited by 230
Effective connectivity of brain networks during self-initiated movement in Parkinson's disease
Wu, T., Wang, L., Hallett, M., Chen, Y., Li, K., & Chan, P. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.074 · Cited by 224
Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age
Ingham, C. A., Hood, S. H., & Arbuthnott, G. W. (1989) · Brain Research · doi:10.1016/0006-8993(89)91686-7 · Cited by 219
TMS Induced Plasticity in Human Cortex
Ziemann, U. (2004) · Reviews in the Neurosciences · doi:10.1515/revneuro.2004.15.4.253 · Cited by 218
Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease
Qamhawi, Z., Towey, D., Shah, B., Pagano, G., Seibyl, J., Marek, K., Borghammer, P., Brooks, D. J., & Pavese, N. (2015) · Brain · doi:10.1093/brain/awv215 · Cited by 218
GABAA receptor subtype specific enhancement of inhibition in human motor cortex
Di Lazzaro, V., Pilato, F., Dileone, M., Ranieri, F., Ricci, V., Profice, P., Bria, P., Tonali, P. A., & Ziemann, U. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.114694 · Cited by 215
Self-citationUnilateral Dopamine Denervation Blocks Corticostriatal LTP
Centonze, D., Gubellini, P., Picconi, B., Calabresi, P., Giacomini, P., & Bernardi, G. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.6.3575 · Cited by 212
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias
Calon, F. (2004) · Brain · doi:10.1093/brain/awh128 · Cited by 212
Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach
Bezard, E., & Gross, C. E. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00006-9 · Cited by 211
Lavoie, B., Smith, Y., & Parent, A. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902890104 · Cited by 203
Effects of apomorphine on globus pallidus neurons in parkinsonian patients
Hutchison, W. D., Levy, R., Dostrovsky, J. O., Lozano, A. M., & Lang, A. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420513 · Cited by 192
Alterations in Brain Connectivity Underlying Beta Oscillations in Parkinsonism
Moran, R. J., Mallet, N., Litvak, V., Dolan, R. J., Magill, P. J., Friston, K. J., & Brown, P. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002124 · Cited by 184
Distribution of the dopamine innervation in the macaque and human thalamus
García-Cabezas, M. Á., Rico, B., Sánchez-González, M. Á., & Cavada, C. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.07.032 · Cited by 181
Wichmann, T., & DeLong, M. R. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0426-6 · Cited by 181
Aoyama, S., Kase, H., & Borrelli, E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05848.2000 · Cited by 180
Vila, M., Périer, C., Féger, J., Yelnik, J., Faucheux, B., Ruberg, M., Raisman‐Vozari, R., Agid, Y., & Hirsch, E. C. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00901.x · Cited by 179
Suárez, L. M., Solís, O., Caramés, J. M., Taravini, I. R., Solís, J. M., Murer, M. G., & Moratalla, R. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.006 · Cited by 179
Rapid Target-Specific Remodeling of Fast-Spiking Inhibitory Circuits after Loss of Dopamine
Gittis, A. H., Hang, G. B., LaDow, E. S., Shoenfeld, L. R., Atallah, B. V., Finkbeiner, S., & Kreitzer, A. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.035 · Cited by 177
Francardo, V., Recchia, A., Popovic, N., Andersson, D., Nissbrandt, H., & Cenci, M. A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.024 · Cited by 177
Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys
Villalba, R. M., Lee, H., & Smith, Y. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.025 · Cited by 171
Toy, W. A., Petzinger, G. M., Leyshon, B. J., Akopian, G. K., Walsh, J. P., Hoffman, M. V., Vučković, M. G., & Jakowec, M. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.017 · Cited by 169
Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., McKenzie, J., McCormick, S., Ruth, T. J., Sossi, V., de la Fuente-Fernandez, R., et al. (2011) · Brain · doi:10.1093/brain/awr233 · Cited by 167
Sharott, A., Gulberti, A., Zittel, S., Tudor Jones, A. A., Fickel, U., Münchau, A., Köppen, J. A., Gerloff, C., Westphal, M., Buhmann, C., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1803-13.2014 · Cited by 166
Thalamic changes in Parkinson's disease
Halliday, G. M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70804-1 · Cited by 166
Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
Ramlackhansingh, A. F., Bose, S. K., Ahmed, I., Turkheimer, F. E., Pavese, N., & Brooks, D. J. (2011) · Neurology · doi:10.1212/wnl.0b013e31821ccce4 · Cited by 163
Protection of nigral cell death by bilateral subthalamic nucleus stimulation
Temel, Y., Visser-Vandewalle, V., Kaplan, S., Kozan, R., Daemen, M. A. R. C., Blokland, A., Schmitz, C., & Steinbusch, H. W. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.082 · Cited by 161
Romanelli, P., Esposito, V., Schaal, D. W., & Heit, G. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.09.008 · Cited by 160
Early synaptic dysfunction in Parkinson's disease: Insights from animal models
Schirinzi, T., Madeo, G., Martella, G., Maltese, M., Picconi, B., Calabresi, P., & Pisani, A. (2016) · Movement Disorders · doi:10.1002/mds.26620 · Cited by 160
Orieux, G., Francois, C., Féger, J., Yelnik, J., Vila, M., Ruberg, M., Agid, Y., & Hirsch, E. C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00011-7 · Cited by 159
Corvol, J.-C., Muriel, M.-P., Valjent, E., Féger, J., Hanoun, N., Girault, J.-A., Hirsch, E. C., & Hervé, D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0676-04.2004 · Cited by 158
Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABAA IPSCs in vitro
Cooper, A. J., & Stanford, I. M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00038-7 · Cited by 156
Fan, K. Y., Baufreton, J., Surmeier, D. J., Chan, C. S., & Bevan, M. D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5750-11.2012 · Cited by 153
A Novel Functionally Distinct Subtype of Striatal Neuropeptide Y Interneuron
Ibáñez-Sandoval, O., Tecuapetla, F., Unal, B., Shah, F., Koós, T., & Tepper, J. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2628-11.2011 · Cited by 152
Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons
Uhl, G. R., Walther, D., Mash, D., Faucheux, B., & Javoy‐Agid, F. (1994) · Annals of Neurology · doi:10.1002/ana.410350421 · Cited by 151
Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain
Zhou, F., Bledsoe, S. B., & Murphy, J. M. (1991) · Brain Research · doi:10.1016/0006-8993(91)90553-8 · Cited by 151
Extrastriatal dopaminergic circuits of the basal ganglia
Rommelfanger, K. S. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00139 · Cited by 150
Ibáñez-Sandoval, O., Tecuapetla, F., Unal, B., Shah, F., Koós, T., & Tepper, J. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5996-09.2010 · Cited by 148
Increased motor cortical facilitation and decreased inhibition in Parkinson disease
Ni, Z., Bahl, N., Gunraj, C. A., Mazzella, F., & Chen, R. (2013) · Neurology · doi:10.1212/wnl.0b013e3182919029 · Cited by 148
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery
Mounayar, S., Boulet, S., Tande, D., Jan, C., Pessiglione, M., Hirsch, E. C., Feger, J., Savasta, M., Francois, C., & Tremblay, L. (2007) · Brain · doi:10.1093/brain/awm208 · Cited by 145
Adenosine A2A Receptors Measured with [11C]TMSX PET in the Striata of Parkinson's Disease Patients
Mishina, M., Ishiwata, K., Naganawa, M., Kimura, Y., Kitamura, S., Suzuki, M., Hashimoto, M., Ishibashi, K., Oda, K., Sakata, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017338 · Cited by 141
Functional reorganization of sensorimotor cortex in early Parkinson disease
Kojović, M., Bologna, M., Kassavetis, P., Murase, N., Palomar, F. J., Berardelli, A., Rothwell, J. C., Edwards, M. J., & Bhatia, K. P. (2012) · Neurology · doi:10.1212/wnl.0b013e318253d5dd · Cited by 141
Chu, H., Atherton, J. F., Wokosin, D. L., Surmeier, D. J., & Bevan, M. D. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.022 · Cited by 137
Zhang, Y., Meredith, G. E., Mendoza‐Elias, N., Rademacher, D. J., Tseng, K. Y., & Steece‐Collier, K. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0288-13.2013 · Cited by 136
Tandé, D., Höglinger, G., Debeir, T., Freundlieb, N., Hirsch, E. C., & François, C. (2006) · Brain · doi:10.1093/brain/awl041 · Cited by 136
Suárez, L. M., Solís, Ó., Aguado, C., Luján, R., & Moratalla, R. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw263 · Cited by 136
Raju, D. V., Ahern, T. H., Shah, D. J., Wright, T. M., Standaert, D. G., Hall, R. A., & Smith, Y. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06136.x · Cited by 135
Zigmond, M. J. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0157 · Cited by 135
Visualization of the medial forebrain bundle using diffusion tensor imaging
Hana, A., Hana, A., Dooms, G., Boecher-Schwarz, H., & Hertel, F. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00139 · Cited by 134
Strafella, A. P., Valzania, F., Nassetti, S. A., Tropeani, A., Bisulli, A., Santangelo, M., & Tassinari, C. A. (2000) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00316-3 · Cited by 134
Metabolic correlates of pallidal neuronal activity in Parkinson's disease
Eidelberg, D. (1997) · Brain · doi:10.1093/brain/120.8.1315 · Cited by 133
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea
Huot, P., Levesque, M., & Parent, A. (2006) · Brain · doi:10.1093/brain/awl332 · Cited by 132
Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice
Parker, P. R. L., Lalive, A. L., & Kreitzer, A. C. (2016) · Neuron · doi:10.1016/j.neuron.2015.12.038 · Cited by 132
Hornykiewicz, O. (1993) · PubMed · Cited by 131
Joyce, J. N. (1991) · Experimental Neurology · doi:10.1016/0014-4886(91)90016-6 · Cited by 126
Fran�ois, C., Savy, C., Jan, C., Tande, D., Hirsch, E. C., & Yelnik, J. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000911)425:1<121::aid-cne10>3.0.co;2-g · Cited by 122
Wile, D. J., Agarwal, P. A., Schulzer, M., Mak, E., Dinelle, K., Shahinfard, E., Vafai, N., Hasegawa, K., Zhang, J., McKenzie, J., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30056-x · Cited by 122
Dopaminergic neurons intrinsic to the striatum
Huot, P., & Parent, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04430.x · Cited by 121
Varani, K., Vincenzi, F., Tosi, A., Gessi, S., Casetta, I., Granieri, G., Fazio, P., Leung, E., MacLennan, S., Granieri, E., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-141044 · Cited by 121
New dopaminergic neurons in Parkinson's disease striatum
Porritt, M. J., Batchelor, P., Hughes, A. J., Kalnins, R. M., Donnan, G. A., & Howells, D. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02437-5 · Cited by 117
Pagano, G., Niccolini, F., Fusar‐Poli, P., & Politis, M. (2016) · Annals of Neurology · doi:10.1002/ana.24859 · Cited by 117
Musacchio, T., Rebenstorff, M., Fluri, F., Brotchie, J. M., Volkmann, J., Koprich, J. B., & Ip, C. W. (2017) · Annals of Neurology · doi:10.1002/ana.24947 · Cited by 117
D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus
Florán, B., Florán, L., Sierra, A., & Aceves, J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00784-2 · Cited by 116
Sen, S., Kawaguchi, A., Truong, Y., Lewis, M. M., & Huang, X. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.036 · Cited by 116
Spieles-Engemann, A. L., Steece‐Collier, K., Behbehani, M. M., Collier, T. J., Wohlgenant, S. L., Kemp, C. J., Cole-Strauss, A., Levine, N. D., Gombash, S. E., Thompson, V. B., et al. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11008 · Cited by 115
Sawle, G. V., Playford, E. D., Brooks, D. J., et al. (1993) · Brain · doi:10.1093/brain/116.4.853 · Cited by 114
Campbell, G. A., Eckardt, M. J., & Weight, F. F. (1985) · Brain Research · doi:10.1016/0006-8993(85)91580-x · Cited by 113
Joyce, J. N., Smutzer, G., Whitty, C. J., Myers, A., & Bannon, M. J. (1997) · Movement Disorders · doi:10.1002/mds.870120609 · Cited by 113
Villar-Menéndez, I., Porta, S., Buira, S. P., Pereira‐Veiga, T., Díaz-Sánchez, S., Albasanz, J. L., Ferrer, I., Martín, M., & Barrachina, M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.030 · Cited by 112
Mura, A., Jackson, D., Manley, M. S., Young, S. J., & Groves, P. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)01104-8 · Cited by 112
Garris, P. A., Walker, Q. D., & Wightman, R. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00003-6 · Cited by 112
Blesa, J., Pifl, C., Sánchez-González, M. A., Juri, C., García-Cabezas, M. A., Adánez, R., Iglesias, E., Collantes, M., Peñuelas, I., Sánchez-Hernández, J. J., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.018 · Cited by 107
Self-citationPritzel, M., Huston, J. P., & Sarter, M. F. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90276-2 · Cited by 106
Palmer, S. J., Ng, B., Abugharbieh, R., Eigenraam, L., & McKeown, M. J. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06753.x · Cited by 106
Are Striatal Tyrosine Hydroxylase Interneurons Dopaminergic?
Xenias, H. S., Ibáñez-Sandoval, O., Koós, T., & Tepper, J. M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0195-15.2015 · Cited by 103
Villalba, R. M., & Smith, Y. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1735-6 · Cited by 102
Villalba, R. M., & Smith, Y. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.011 · Cited by 101
Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease
Xuereb, J. H., Perry, R. H., Candy, J. M., Perry, E. K., Marshall, E., & Bonham, J. R. (1991) · PubMed · doi:10.25405/ncl.34085541 · Cited by 99
Joint amplitude and connectivity compensatory mechanisms in Parkinson's disease
Palmer, S. J., Li, J., Wang, Z. J., & McKeown, M. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.012 · Cited by 98
Heinsen, H., Rüb, U., Gangnus, D., Jungkunz, G., Bauer, M., Ulmar, G., Bethke, B., Schüler, M., Böcker, F. M., Eisenmenger, W., et al. (1996) · Acta Neuropathologica · doi:10.1007/s004010050408 · Cited by 97
Hassani, O.-K., & Féger, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00765-9 · Cited by 97
Thobois, S., Jahanshahi, M., Pinto, S., Frackowiak, R. S. J., & Limousin, P. D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.04.039 · Cited by 95
Differential processing of thalamic information via distinct striatal interneuron circuits
Assous, M., Kaminer, J., Shah, F., Garg, A., Koós, T. Z., & Tepper, J. M. (2017) · Nature Communications · doi:10.1038/ncomms15860 · Cited by 95
Pathophysiological roles for purines
Morelli, M., Carta, A. R., Kachroo, A., & Schwarzschild, M. A. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)83010-9 · Cited by 93
Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson’s disease
Villalba, R. M., Wichmann, T., & Smith, Y. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0507-9 · Cited by 93
Sa�udo-Pe�a, M. C., Force, M., Tsou, K., Miller, A. S., & Walker, J. M. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2<221::aid-syn12>3.0.co;2-4 · Cited by 93
Roedter, A., Winkler, C., Samii, M., Walter, G. F., Brandis, A., & Nikkhah, G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1098 · Cited by 90
Basal ganglia–cortical interactions in Parkinsonian patients
Marreiros, A. C., Cagnan, H., Moran, R. J., Friston, K. J., & Brown, P. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2012.10.088 · Cited by 90
Boulet, S., Mounayar, S., Poupard, A., Bertrand, A., Jan, C., Pessiglione, M., Hirsch, E. C., Feuerstein, C., François, C., Féger, J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3465-08.2008 · Cited by 89
Quiroga‐Varela, A., Walters, J. R., Brazhnik, E. S., Marín, C., & Obeso, J. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.05.010 · Cited by 89
Self-citationAn Overview of Adenosine A2A Receptor Antagonists in Parkinson's Disease
Jenner, P. G. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00003-9 · Cited by 89
Morphologic changes of dendritic spines of striatal neurons in the levodopa‐induced dyskinesia model
Nishijima, H., Suzuki, S., Kon, T., Funamizu, Y., Ueno, T., Haga, R., Suzuki, C., Arai, A., Kimura, T., Suzuki, C., et al. (2014) · Movement Disorders · doi:10.1002/mds.25826 · Cited by 88
Dopamine heteroreceptor complexes as therapeutic targets in Parkinson’s disease
Fuxé, K., Guidolin, D., Agnati, L. F., & Borroto‐Escuela, D. O. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.981529 · Cited by 88
Rozas, G., Liste, I., Guerra, M. J., & Labandeira-García, J. L. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00198-0 · Cited by 88
Zhu, Z., Bartol, M., Shen, K., & Johnson, S. W. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02543-x · Cited by 86
Strecker, K., Wegner, F., Hesse, S., Becker, G., Patt, M., Meyer, P., Lobsien, D., Schwarz, J., & Sabri, O. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5666-5 · Cited by 85
Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson’s disease
Singh, A. P., Mewes, K., Gross, R. E., DeLong, M. R., Obeso, J. A., & Papa, S. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606792113 · Cited by 84
Self-citationKojović, M., Kassavetis, P., Bologna, M., Pareés, I., Rubio‐Agusti, I., Beraredelli, A., Edwards, M. J., Rothwell, J. C., & Bhatia, K. P. (2015) · Movement Disorders · doi:10.1002/mds.26167 · Cited by 82
Kliem, M. A., Maidment, N. T., Ackerson, L. C., Chen, S., Smith, Y., & Wichmann, T. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00171.2007 · Cited by 79
Mintz, I. M., Hammond, C., & Féger, J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90971-6 · Cited by 79
Morphological changes of glutamatergic synapses in animal models of Parkinson’s disease
Villalba, R. M., Mathai, A., & Smith, Y. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00117 · Cited by 78
Wichmann, T., Bergman, H., & DeLong, M. R. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1736-5 · Cited by 78
Galván, A., & Smith, Y. (2011) · Basal Ganglia · doi:10.1016/j.baga.2011.09.001 · Cited by 77
Serotonergic sprouting in primate MTP-induced hemiparkinsonism
Gaspar, P., Febvret, A., & Colombo, J. A. (1993) · Experimental Brain Research · doi:10.1007/bf00230443 · Cited by 77
Striatal spine plasticity in Parkinson's disease: pathological or not?
Smith, Y., Villalba, R. M., & Raju, D. V. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70805-3 · Cited by 76
Maeda, T., Kannari, K., Shen, H., Arai, A., Tomiyama, M., Matsunaga, M., & Suda, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00295-7 · Cited by 75
Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age
Vernaleken, I., Weibrich, C., Siessmeier, T., Buchholz, H., Rösch, F., Heinz, A., Cumming, P. D., Stoeter, P., Bartenstein, P., & Gründer, G. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.10.013 · Cited by 75
How does Parkinson's disease begin? The role of compensatory mechanisms
Obeso, J. A., Rodríguez-Oroz, M. C., Lanciego, J. L., & Rodríguez, M. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.12.006 · Cited by 75
Self-citationJoyce, J. N. (1991) · Experimental Neurology · doi:10.1016/0014-4886(91)90017-7 · Cited by 73
Kozina, E. A., Khakimova, G. R., Хаиндрава, В. Г., Kucheryanu, V. G., Vorobyeva, N. E., Краснов, А. Н., Georgieva, S., Goff, L. K., & Ugrumov, M. V. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.03.028 · Cited by 71
Trevitt, J. T., Carlson, B., Nowend, K. L., & Salamone, J. D. (2001) · Psychopharmacology · doi:10.1007/s002130100708 · Cited by 70
Pre‐synaptic dopaminergic compensation after moderate nigrostriatal damage in non‐human primates
Perez, X. A., Parameswaran, N., Huang, L. Z., O’Leary, K. T., & Quik, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05268.x · Cited by 70
6‐[18F]Fluoro‐L‐DOPA probes dopamine turnover rates in central dopaminergic structures
Barrio, J. R., Huang, S., Melega, W. P., Yu, D., Hoffman, J. M., Schneider, J. S., Satyamurthy, N., Mazziotta, J. C., & Phelps, M. E. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270408 · Cited by 69
Intralaminar nuclei of the thalamus in Lewy body diseases
Brooks, D., & Halliday, G. M. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.08.014 · Cited by 69
Bézard, E., Boraud, T., Bioulac, B. H., & Gross, C. E. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00226-1 · Cited by 67
Blesa, J. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00092 · Cited by 65
Self-citationDopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat
Hauber, W., & Lutz, S. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00102-3 · Cited by 63
Fischer, D. L., Kemp, C. J., Cole-Strauss, A., Polinski, N. K., Paumier, K. L., Lipton, J. W., Steece‐Collier, K., Collier, T. J., Buhlinger, D. J., & Sortwell, C. E. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2060-16.2017 · Cited by 62
Galván, A., Hu, X., Rommelfanger, K. S., Paré, J., Khan, Z. U., Smith, Y., & Wichmann, T. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00849.2013 · Cited by 61
Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys
Pifl, C., & Hornykiewicz, O. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.03.013 · Cited by 58
Positron emission tomography in premotor Parkinson's disease
Stoessl, A. J. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70041-5 · Cited by 58
Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease
Simioni, A. C., Dagher, A., & Fellows, L. K. (2017) · Cortex · doi:10.1016/j.cortex.2017.05.021 · Cited by 58
Sossi, V., Dinelle, K., Topping, G. J., Holden, J. E., Doudet, D. J., Schulzer, M., Ruth, T. J., Stoessl, A. J., & de la Fuente‐Fernández, R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05904.x · Cited by 57
Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism
Henderson, J. M., Schleimer, S. B., Allbutt, H. N., Dabholkar, V., Abela, D., Jovic, J., & Quinlivan, M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.017 · Cited by 57
Ni, Z., Gao, D., Bouali‐Benazzouz, R., Benabid, A. L., & Benazzouz, A. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01644.x · Cited by 57
Nakashima, A., Ota, A., Kaneko, Y. S., Mori, K., Nagasaki, H., & Nagatsu, T. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0828-5 · Cited by 53
Ruskin, D. N., Bergstrom, D. A., & Walters, J. R. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00844.2001 · Cited by 52
Zooming in on the small: The plasticity of striatal dendritic spines in l ‐DOPA–Induced dyskinesia
Fieblinger, T., & Cenci, M. A. (2015) · Movement Disorders · doi:10.1002/mds.26139 · Cited by 51
The crossed mesostriatal projection: neurochemistry and developmental response to lesion
Altar, A. C., Neve, K. A., Loughlin, S. E., Marshall, J. F., & Fallon, J. H. (1983) · Brain Research · doi:10.1016/0006-8993(83)90157-9 · Cited by 51
Ballanger, B., Beaudoin‐Gobert, M., Neumane, S., Epinat‐Duclos, J., Météreau, É., Duperrier, S., Broussolle, E., Thobois, S., Bonnefoi, F., Tourvielle, C., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2010-15.2016 · Cited by 51
Sa√±udo-Pe√±a, M. C., & Walker, J. M. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199801)28:1<27::aid-syn4>3.0.co;2-e · Cited by 51
Changes in brain dopamine receptors in MPTP parkinsonian monkeys followingL-dopa treatment
Alexander, G. M., Schwartzman, R. J., Grothusen, J. R., Brainard, L., & Gordon, S. W. (1993) · Brain Research · doi:10.1016/0006-8993(93)91069-5 · Cited by 49
Laulumaa, V., Kuikka, J. T., Soininen, H., Bergström, K., Länsimies, E., & Riekkinen, P. J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540050059016 · Cited by 49
Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys
Gagnon, D., Grégoire, L., Paolo, T. D., & Parent, M. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1125-5 · Cited by 48
Cited by
Lang, A. E., & Espay, A. J. (2018) · Movement Disorders · doi:10.1002/mds.27360 · Cited by 370
Modeling Parkinson’s disease in midbrain-like organoids
Smits, L. M., Reinhardt, L., Reinhardt, P., Glatza, M., Monzel, A. S., Stanslowsky, N., Rosato-Siri, M. D., Zanon, A., Antony, P. M., Bellmann, J., et al. (2019) · npj Parkinson's Disease · doi:10.1038/s41531-019-0078-4 · Cited by 356
Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases
Fão, L., Mota, S. I., & Rego, A. C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100942 · Cited by 270
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Blesa, J., Foffani, G., Dehay, B., Bezard, E., & Obeso, J. A. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00542-9 · Cited by 232
“Modified with permission from ref.(25), Elsevier.”
Self-citationLavisse, S., Goutal, S., Wimberley, C., Tonietto, M., Bottlaender, M., Gervais, P., Kuhnast, B., Peyronneau, M.-A., Barret, O., Lagarde, J., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.11.011 · Cited by 127
Metadata
- Authors
- Blesa, J., Trigo-Damas, I., Dileone, M., del Rey, N. L.-G., Hernandez, L. F., & Obeso, J. A.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 298
- Issue
- Pt B
- Pages
- 148-161
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2764237245
- Cited by
- 256
- References
- 238
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.